NFKB1 and cancer: Li and coworkers have reported that exosomes derived from prostate cancer can increase the expression of CXCR4 in MDSCs by activating the TLR2/NF-κB pathway, thereby promoting the migration of MDSCs to the TIME and enhancing the formation of a cancer immunosuppressive microenvironment (107).